Home LiteratureArticle Details
PMID: 11120768 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other.

The Journal of experimental medicine ·Vol. 192 ·No. 12 ·2000-12-18 ·Pages 1707-18

Domen J, Weissman IL

Abstract

Growth factors can cause cells to proliferate, differentiate, survive, or die. Distinguishing between these responses is difficult in multicellular, multiparameter systems. Yet this is essential to understand the impact on cells like hematopoietic stem cells (HSCs), which have strict and still poorly understood growth factor requirements. Single cell plating in serum-free medium allows direct assessment of growth factor responses. The range of tested factors can be expanded if the cells are protected from growth factor deprivation-induced apoptosis. BCL-2 is overexpressed in HSCs of H2K-BCL-2 transgenic mice, protecting them from many apoptotic stimuli. The response of single wild-type and transgenic HSCs to stimulations with individual factors was tested. Surprisingly, we find that high level BCL-2 expression does not prevent rapid death under serum-free conditions, even though it does in the presence of serum. We also find that transgenic, but not wild-type cells, survive and proliferate rapidly in response to steel factor (Kit ligand). These studies show that two separate signals are necessary to prevent apoptosis in HSCs, and that Kit ligand by itself provides a strong proliferative stimulus to HSCs. However, the proliferative response does not result in self-renewal, but in differentiation to all known hematopoietic oligolineage progenitors.

MeSH Terms
Animals Apoptosis/drug effects Cell Count Cell Differentiation/drug effects Cell Division/drug effects Cell Size/drug effects Cells, Cultured Culture Media, Serum-Free Gene Expression Regulation/drug effects Hematopoietic Stem Cells/cytology,drug effects,metabolism Histocytochemistry Interleukin-3/pharmacology Mast Cells/cytology,drug effects Mice Mice, Transgenic Peritoneal Cavity/cytology Proto-Oncogene Proteins c-bcl-2/genetics,metabolism Proto-Oncogene Proteins c-kit/metabolism Signal Transduction/drug effects Stem Cell Factor/pharmacology Stem Cells/cytology,drug effects Thrombopoietin/pharmacology
Chemicals
Culture Media, Serum-Free Interleukin-3 Proto-Oncogene Proteins c-bcl-2 Stem Cell Factor Thrombopoietin Proto-Oncogene Proteins c-kit
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Domen J
Department of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
Weissman I L
References (71)
71 references, click to expand
  1. Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells.
    Blood. 1993 Sep 1;82(5):1445-52 PMID: 7689870
  2. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors.
    Cell. 1993 Sep 10;74(5):823-32 PMID: 7690686
  3. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice.
    Cell. 1997 Jun 27;89(7):1021-31 PMID: 9215625
  4. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.
    Cell. 1997 Jun 27;89(7):1033-41 PMID: 9215626
  5. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice.
    Immunity. 1997 Jul;7(1):155-62 PMID: 9252128
  6. Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion.
    Curr Biol. 1997 Oct 1;7(10):805-8 PMID: 9368765
  7. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Int J Biochem Cell Biol. 1999 Oct;31(10):1027-35 PMID: 10582337
  8. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate.
    Mol Med Today. 1999 May;5(5):201-8 PMID: 10322312
  9. Thrombopoietin and hematopoietic stem cell development.
    Ann N Y Acad Sci. 1999 Apr 30;872:314-9 PMID: 10372133
  10. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    EMBO J. 1999 Sep 1;18(17):4754-65 PMID: 10469654
  11. Reversible expression of CD34 by murine hematopoietic stem cells.
    Blood. 1999 Oct 15;94(8):2548-54 PMID: 10515856
  12. Symmetry of initial cell divisions among primitive hematopoietic progenitors is independent of ontogenic age and regulatory molecules.
    Blood. 1999 Oct 15;94(8):2595-604 PMID: 10515863
  13. Identification of a lineage of multipotent hematopoietic progenitors.
    Development. 1997 May;124(10):1929-39 PMID: 9169840
  14. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice.
    Cell. 1997 Jun 27;89(7):1011-9 PMID: 9215624
  15. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2.
    Oncogene. 1999 Dec 9;18(52):7584-93 PMID: 10602518
  16. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.
    Immunity. 1999 Dec;11(6):709-19 PMID: 10626893
  17. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential.
    J Exp Med. 2000 Jan 17;191(2):253-64 PMID: 10637270
  18. Stem cells: units of development, units of regeneration, and units in evolution.
    Cell. 2000 Jan 7;100(1):157-68 PMID: 10647940
  19. The biology of stem cell factor and its receptor C-kit.
    Int J Biochem Cell Biol. 1999 Oct;31(10):1037-51 PMID: 10582338
  20. Early signaling pathways activated by c-Kit in hematopoietic cells.
    Int J Biochem Cell Biol. 1999 Oct;31(10):1053-74 PMID: 10582339
  21. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells.
    Blood. 1993 Dec 1;82(11):3327-32 PMID: 8241503
  22. Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of white spotting and steel mutant mice.
    J Exp Med. 1994 Jun 1;179(6):1777-87 PMID: 7515099
  23. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells.
    Blood. 1994 Jul 15;84(2):408-14 PMID: 7517713
  24. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7553-7 PMID: 7519782
  25. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Exp Hematol. 1995 May;23(5):413-21 PMID: 7536683
  26. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.
    Immunity. 1994 Nov;1(8):661-73 PMID: 7541305
  27. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division.
    Blood. 1995 Sep 1;86(5):1757-64 PMID: 7544641
  28. The purification and characterization of fetal liver hematopoietic stem cells.
    Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10302-6 PMID: 7479772
  29. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.
    EMBO J. 1995 Dec 15;14(24):6136-47 PMID: 8557033
  30. Homing of fluorescently labeled murine hematopoietic stem cells.
    Exp Hematol. 1996 Feb;24(2):129-40 PMID: 8641334
  31. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.
    J Exp Med. 1996 May 1;183(5):2219-26 PMID: 8642331
  32. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells.
    Blood. 1996 Jun 15;87(12):4998-5005 PMID: 8652812
  33. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    Science. 1996 Jul 12;273(5272):242-5 PMID: 8662508
  34. Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo.
    Blood. 1996 Oct 15;88(8):2852-8 PMID: 8874181
  35. Cycle initiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo.
    Blood. 1996 Dec 1;88(11):4149-58 PMID: 8943849
  36. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry.
    EMBO J. 1996 Dec 16;15(24):6979-90 PMID: 9003774
  37. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment.
    Blood. 1997 May 15;89(10):3596-606 PMID: 9160664
  38. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells.
    Blood. 1997 May 15;89(10):3624-35 PMID: 9160667
  39. Identification of clonogenic common lymphoid progenitors in mouse bone marrow.
    Cell. 1997 Nov 28;91(5):661-72 PMID: 9393859
  40. Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx.
    Blood. 1998 Mar 15;91(6):1891-900 PMID: 9490671
  41. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation.
    Blood. 1998 Apr 1;91(7):2272-82 PMID: 9516125
  42. Advances in hematopoietic stem cell culture.
    Curr Opin Biotechnol. 1998 Apr;9(2):146-51 PMID: 9588003
  43. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells.
    Blood. 1998 Jun 1;91(11):4084-91 PMID: 9596653
  44. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136.
    Curr Biol. 1998 Jun 18;8(13):779-82 PMID: 9651683
  45. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation.
    Blood. 1998 Jul 15;92(2):345-7; discussion 352 PMID: 9657727
  46. Do stem cells play dice?
    Blood. 1998 Jul 15;92(2):348-51; discussion 352 PMID: 9657728
  47. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6.
    Blood. 1998 Jul 15;92(2):452-61 PMID: 9657744
  48. Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: transduction of the negative signals by betac and betaIL-3 proteins of IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor.
    Blood. 1998 Aug 1;92(3):901-7 PMID: 9680358
  49. The thrombopoietic factor, Mpl-ligand.
    Int J Biochem Cell Biol. 1998 Jun;30(6):657-60 PMID: 9695022
  50. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia.
    Immunity. 1998 Jul;9(1):47-57 PMID: 9697835
  51. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.
    J Immunol. 1998 Nov 1;161(9):4652-60 PMID: 9794394
  52. Influence of cytokines on the growth kinetics and immunophenotype of daughter cells resulting from the first division of single CD34(+)Thy-1(+)lin- cells.
    Blood. 1998 Dec 1;92(11):4098-107 PMID: 9834215
  53. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development.
    Immunity. 1999 Feb;10(2):173-82 PMID: 10072070
  54. The role of cytokine receptor signaling in lymphocyte development.
    Curr Opin Immunol. 1999 Apr;11(2):157-66 PMID: 10322150
  55. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
    Nature. 2000 Mar 9;404(6774):193-7 PMID: 10724173
  56. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro.
    Blood. 2000 Sep 1;96(5):1748-55 PMID: 10961873
  57. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways.
    Blood. 2000 Sep 1;96(5):1764-71 PMID: 10961875
  58. Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. II. Effects on mast cell development.
    Exp Hematol. 1983 Jul;11(6):461-6 PMID: 6352298
  59. Purification and characterization of mouse hematopoietic stem cells.
    Science. 1988 Jul 1;241(4861):58-62 PMID: 2898810
  60. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Nature. 1988 Sep 29;335(6189):440-2 PMID: 3262202
  61. The lymphopoietic microenvironment in bone marrow.
    Adv Cancer Res. 1990;54:235-72 PMID: 2404379
  62. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W.
    EMBO J. 1990 Jun;9(6):1805-13 PMID: 1693331
  63. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors.
    EMBO J. 1990 Oct;9(10):3287-94 PMID: 1698611
  64. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6382-6 PMID: 1712491
  65. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.
    Blood. 1991 Sep 1;78(5):1223-9 PMID: 1715219
  66. Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor.
    Int J Cell Cloning. 1991 Sep;9(5):451-60 PMID: 1720154
  67. Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow.
    J Exp Med. 1992 Jan 1;175(1):175-84 PMID: 1346154
  68. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation.
    Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1502-6 PMID: 1371359
  69. Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset.
    Blood. 1992 Oct 15;80(8):1957-64 PMID: 1356513
  70. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors.
    Blood. 1993 Feb 1;81(3):610-6 PMID: 7678992
  71. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor.
    Blood. 1993 Aug 1;82(3):762-70 PMID: 7687891
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2000-12-18
Pages
1707-18
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2213494
Subset
IM
Grants
NCI NIH HHS · CA42551 · United States
NIDDK NIH HHS · P01DK53074 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]